Berzosertib (VE-822) inhibits gastric cancer cell proliferation via base excision repair system

Overview of attention for article published in Cancer Management and Research, September 2019

Altmetric Badge

About this Attention Score

Above-average Attention Score compared to outputs of the same age and source (51st percentile)

Mentioned by

twitter: 2 X users

Citations

dimensions_citation: 12 Dimensions

Readers on

mendeley: 14 Mendeley

Summary X Dimensions citations

So far, Dimensions has found 12 publications that cite this research output.

12

The most recent citing publications are shown below. View all 12 publications that cite this research output on Dimensions.

The ATR inhibitor berzosertib acts as a radio- and chemosensitizer in head and neck squamous cell carcinoma cell lines

Article in Investigational New Drugs (November 2023)

Senescence‐based colorectal cancer subtyping reveals distinct molecular characteristics and therapeutic strategies

Article in MedComm (July 2023)

Determination of the effects of fusaric acid, a mycotoxin, on cytotoxicity, gamma-H2AX, 8-hydroxy-2 deoxyguanosine and DNA repair gene expressions in pancreatic cancer cells

Article in Toxicon (June 2023)